BioMed Central | Articles which cite: Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.
Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, Ambrose C, Dayer JM
Arthritis Res 2002, 4:126-33
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis. Bernier SG, Lazarus DD, Clark E, Doyle B, Labenski MT, Thompson CD, Westlin WF, Hannig G Proc Natl Acad Sci U S A 2004 Jul 20, 101:10768-73 [PubMed Central] [PubMed] [Related articles]
2.	TWEAK induces liver progenitor cell proliferation. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Baestcher M, Wang B, Bissell DM, Burkly LC J Clin Invest 2005 Sep, 115:2330-40 [PubMed Central] [PubMed] [Related articles]
3.	The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Brown SA, Richards CM, Hanscom HN, Feng SL, Winkles JA Biochem J 2003 Apr 15, 371:395-403 [PubMed Central] [PubMed] [Related articles]
4.	TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules. Brown SA, Hanscom HN, Vu H, Brew SA, Winkles JA Biochem J 2006 Jul 15, 397:297-304 [PubMed Central] [PubMed] [Related articles]
5.	A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Yepes M, Brown SA, Moore EG, Smith EP, Lawrence DA, Winkles JA Am J Pathol 2005 Feb, 166:511-20 [PubMed Central] [PubMed] [Related articles]
6.	TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS EMBO J 2006 Dec 13, 25:5826-39 [PubMed Central] [PubMed] [Related articles]
7.	Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T Clin Exp Immunol 2006 Dec, 146:540-9 [PubMed Central] [PubMed] [Related articles]
8.	The cytokine TWEAK modulates renal tubulointerstitial inflammation. Sanz AB, Justo P, Sanchez-Niño MD, Blanco-Colio LM, Winkles JA, Kreztler M, Jakubowski A, Blanco J, Egido J, Ruiz-Ortega M, Ortiz A J Am Soc Nephrol 2008 Apr, 19:695-703 [PubMed Central] [PubMed] [Related articles]
9.	Molecular subsets in the gene expression signatures of scleroderma skin. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML PLoS One 2008, 3:e2696 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us